Taken together, our results not only validate the importance of local CCR2 targeting in preventing the structural damage of cartilage and bone following injury but also confirm our polymeric, biodegradable microplates as successful drug carriers for therapeutic purposes in arthritis. The gene discussed is CCR2; the disease is Arthritis.